On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…
On Apr. 7, 2020, the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application by…
On Apr. 7, 2020, researchers at the University of Iowa and the University of Georgia announced they had…
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
On Apr. 7, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
On Apr. 6, 2020, new COVID-19 estimated find that, among European nations, the peak daily death rate from…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…
On Apr. 6, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Apr. 6, 2020, VGX announced successful implementation of new RNA production services through completion of all Phase…
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
On Apr. 6, 2020, RedHill Biopharma announced the first patient with confirmed coronavirus (COVID-19) diagnosis had been dosed…
On Apr. 6, 2020, RedHill Biopharma announced it has received authorization from the Italian National Institute for Infectious…
On Apr. 6, 2020, Getinge announced it was ramping up the production capacity stepwise at its production facility…
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
On Apr. 6, 2020, Intravacc announced development of an intranasal vaccine against COVID-19 that will be developed through…
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
On Apr. 6, 2020, Innovation Pharma announced that it is engaged in discussions with health care provider networks…
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
On Apr. 6, 2020, to address the need for N95 masks, an interdisciplinary research team at the University…
On Apr. 6, 2020, 3M announced a partnership with Cummins to increase the production of high efficiency particulate…
On Apr. 6, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…